Showing results (151-160 of 1,318) with videos related to
Sort By:
Pageof 132
Medical Hypotheses|January 11, 2018
Nigral depigmentation reflects monoamine exhaustion as initial step to Parkinson's diseaseThomas Müller, Willi KohlheppHistory of Psychiatry|April 17, 2019
The 'Poitrot Report', 1945: the first public document on Nazi euthanasiaThomas Müller, Bernd ReicheltJournal of Neural Transmission (Vienna, Austria : 1996)|January 7, 2014
Levodopa-related cysteinyl-glycine and cysteine reduction with and without catechol-O-methyltransferase inhibition in Parkinson's disease patientsThomas Müller, Siegfried MuhlackCellular Microbiology|January 10, 2018
Tailored environments to study motile cells and pathogensJulianne Mendi Muthinja, Johanna Ripp, Timothy Krüger, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 27, 2009
Cysteine elevation in levodopa-treated patients with Parkinson's diseaseThomas Müller, Wilfried KuhnOecologia|March 18, 2017
Aphid honeydew and its effect on the phyllosphere microflora of Picea abies (L.) KarstBernhard Stadler, Thomas MüllerJournal of Neural Transmission (Vienna, Austria : 1996)|July 17, 2012
Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson's disease under duodopa® therapySabine Skodda, Thomas MüllerExpert Opinion on Pharmacotherapy|August 24, 2006
Levodopa, motor fluctuations and dyskinesia in Parkinson's diseaseThomas Müller, Hermann RussJournal of Neural Transmission (Vienna, Austria : 1996)|February 3, 2020
Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson's diseaseThomas Müller, Ali HaratiJournal of Neural Transmission (Vienna, Austria : 1996)|March 24, 2018
Monoamine oxidase-B inhibitors in the treatment of Parkinson's disease: clinical-pharmacological aspectsPeter Riederer, Thomas MüllerPageof 132